157 related articles for article (PubMed ID: 27918341)
1. Two Cases of Suspected Rejection of Polydimethylsiloxane Urethral Bulking Agent.
Bennett AT; Lukacz ES
Female Pelvic Med Reconstr Surg; 2017; 23(3):e10-e11. PubMed ID: 27918341
[TBL] [Abstract][Full Text] [Related]
2. Can Urethral Bulking Agents Salvage Failed Slings?
Dray EV; Hall M; Covalschi D; Cameron AP
Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
[TBL] [Abstract][Full Text] [Related]
3. Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety.
de Vries AM; van Breda HMK; Fernandes JG; Venema PL; Heesakkers JPFA
Urol Int; 2017; 99(1):91-97. PubMed ID: 28152525
[TBL] [Abstract][Full Text] [Related]
4. Periurethral injection of the genitourinary spheroidal membrane.
Darson MF; Malizia AA; Barrett DM
J Endourol; 1996 Jun; 10(3):283-6. PubMed ID: 8740393
[TBL] [Abstract][Full Text] [Related]
5. Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up.
Futyma K; Nowakowski Ł; Gałczyński K; Miotła P; Rechberger T
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():68-72. PubMed ID: 27825030
[TBL] [Abstract][Full Text] [Related]
6. Female stress urinary incontinence: office-based urethral bulking agent procedure.
Ramsden M; Williams E; Siegel S
Urol Nurs; 2010; 30(5):297-305. PubMed ID: 21067095
[TBL] [Abstract][Full Text] [Related]
7. [Intrinsic sphincter deficiency and female urinary incontinence].
Cour F; Le Normand L; Lapray JF; Hermieu JF; Peyrat L; Yiou R; Donon L; Wagner L; Vidart A;
Prog Urol; 2015 Jun; 25(8):437-54. PubMed ID: 25864653
[TBL] [Abstract][Full Text] [Related]
8. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results.
Ghoniem G; Corcos J; Comiter C; Westney OL; Herschorn S
J Urol; 2010 Apr; 183(4):1444-9. PubMed ID: 20171691
[TBL] [Abstract][Full Text] [Related]
9. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
Siddiqui ZA; Abboudi H; Crawford R; Shah S
Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
[TBL] [Abstract][Full Text] [Related]
10. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
[TBL] [Abstract][Full Text] [Related]
11. Urethral bulking agents for female stress urinary incontinence.
Hussain SM; Bray R
Neurourol Urodyn; 2019 Mar; 38(3):887-892. PubMed ID: 30801773
[TBL] [Abstract][Full Text] [Related]
12. A new device for the treatment of female stress urinary incontinence.
van Veggel L; Morrell M; Harris C; Dormans-Linssen M
Proc Inst Mech Eng H; 2003; 217(4):317-21. PubMed ID: 12885203
[TBL] [Abstract][Full Text] [Related]
13. Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency.
Shi LB; Cai HX; Chen LK; Wu Y; Zhu SA; Gong XN; Xia YX; Ouyang HW; Zou XH
Biomaterials; 2014 Feb; 35(5):1519-30. PubMed ID: 24275524
[TBL] [Abstract][Full Text] [Related]
14. Update on Urethral Bulking for Stress Urinary Incontinence in Women.
Zheng Y; Rovner E
Curr Urol Rep; 2022 Oct; 23(10):203-209. PubMed ID: 35781870
[TBL] [Abstract][Full Text] [Related]
15. [Periurethral injection in the treatment of stress urinary incontinence in women].
Schiøtz HA
Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2627-9. PubMed ID: 9324819
[TBL] [Abstract][Full Text] [Related]
16. [Urethral Macroplastique injection as a treatment for female stress incontinence].
Sander P; Mouritsen AL; Lose G
Ugeskr Laeger; 2004 Aug; 166(36):3100-2. PubMed ID: 15387310
[No Abstract] [Full Text] [Related]
17. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.
Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T
Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616
[TBL] [Abstract][Full Text] [Related]
18. [Bulking agents and their place in the treatment of urinary stress incontinence].
Achtari C; Meyer S; De Grandi P
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):39-44. PubMed ID: 16452819
[TBL] [Abstract][Full Text] [Related]
19. [Transurethral injections under local anaesthesia for ambulatory treatment of stress urinary incontinence in women: indications, feasibility and results].
de Tayrac R; Cortesse A; Fernandez H; Fritel X
J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 1):702-10. PubMed ID: 16270009
[TBL] [Abstract][Full Text] [Related]
20. Suburethral mass formation after injection of polydimethylsiloxane (Macroplastique®) urethral bulking agent.
Wasenda EJ; Nager CW
Int Urogynecol J; 2016 Dec; 27(12):1935-1936. PubMed ID: 27530519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
